IPOL (Sanofi Pasteur) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "IPOL Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The historic growth of the IPOL market is largely due to global initiatives for polio eradication, safety concerns with live vaccines, and robust government immunization programs. Support from international health organizations and the demonstrated efficacy of inactivated polio vaccines (IPV) further bolstered this progress.
Looking forward, market growth is anticipated to be driven by ongoing surveillance for polio eradication, adult booster program expansion, increasing demand for travel vaccinations, continual public health funding, and enhanced cold chain logistics. Key trends include the sustained use of IPV, a shift from oral polio vaccines, expanded routine immunization coverage, and a focus on travel and adult immunization efforts.
Rising global travel and migration are expected to significantly boost the IPOL market. As individuals move internationally for reasons ranging from work and education to safety and economic opportunities, a robust demand for vaccination arises, especially in regions where polio remains endemic. For instance, in May 2024, an increase in international tourism was reported with 285 million tourists in just the first quarter, marking a 20% rise from the previous year. This trend underpins the essential role of IPOL in safely enabling worldwide mobility by requiring vaccination proof for entry in some countries, thus supporting polio eradication globally.
Increased birth rates also contribute notably to the growth of the IPOL market. As birth rates climb, driven by improved healthcare and changing societal norms, there is a heightened need for vaccination to protect infants and children from polio. Notably, the CDC reported a 1% rise in births in the USA from 2023 to 2024, totaling 3,628,934 births, further underscoring the correlation between birth rates and IPOL demand.
Government initiatives and vaccination programs play a critical role in amplifying IPOL market growth through coordinated efforts to make vaccines broadly accessible and included in routine immunization schedules. These actions bolster demand and contribute to the global objective of polio eradication. For example, the CDC noted stable global immunization coverage between 2022 and 2023, emphasizing the role of public health collaborations in achieving high vaccination rates.
Major industry players like Sanofi Pasteur SA are central to this landscape. North America leads in market size as of 2025, with the Asia-Pacific region predicted to be the fastest-growing market segment. Geographical focus extends across Asia-Pacific, Western and Eastern Europe, North America, South America, the Middle East, and Africa, with key nations including Australia, India, China, Japan, the USA, and Canada.
Tariffs can affect the market by escalating production and distribution costs, potentially challenging procurement and rollout strategies in import-reliant regions. However, they are also incentivizing domestic manufacturing, ultimately enhancing vaccine security.
This comprehensive market report offers crucial insights, covering global market size, regional shares, competitive analysis, market trends, and opportunities. It provides an in-depth examination of the industry scenario, equipping stakeholders with the knowledge necessary for navigating the evolving IPOL market landscape.
Report Highlights
For more information about this report visit https://www.researchandmarkets.com/r/oofp8l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.